Our Team
Sedric Pankras, PhD, MBA
FOUNDER & MANAGING DIRECTOR
Education
- MBA, Schulich School of Business, Canada (2018)
- Grad. Diploma in Health Industry Mgmt., Schulich School of Business, Canada (2018)
- Certificate, Big Data & Predictive Analytics, TMU, Canada (2016)
- PhD, Life Sciences discipline, University of Toronto, Canada (2011)
Experience
- Business Development Professional, Industry Partnerships & Commercialization Office (IP&C) - The Hospital for Sick Children, Canada (2020 - Continuing)
- Business Analyst, Technology Development & Commercialization division (TDC ) - University Health Network, Canada (2017 - 2020)
- Strategy Consultant, First Principles Advisories, USA (2018 - 2019)
- Biotechnology Consultant, Savant Technical Consulting, Canada (2014 - 2016)
- Postdoctoral Researcher & Project(s) Manager, University of Toronto, Canada (2011 - 2014)
Profile
Sedric Pankras is a visionary business development professional with a remarkable track record and over a decade of experience in R&D, IP commercialization, partnership development, and strategic business consulting within the dynamic field of biotechnology and life sciences. Sedric's unique strength lies in his comprehensive understanding of the scientific, business development, and transactional aspects of the biotechnology and life science industry. With his unique background, market-savvy strategic insights and financial acumen, Sedric has consistently demonstrated his ability to turn groundbreaking scientific advancements into thriving business opportunities. Proficient in valuation, deal analysis and deal structuring, Sedric has made significant contributions to the negotiation and execution of several high-value deals (licenses to Adela Inc., Treadwell Therapeutics Inc., TraferoxTechnologies Inc., Point Biopharma, Radiant Biotherapeutics Inc.) propelling technology commercialization and businesses forward. As the founder and driving force behind KAVAADAM consulting services, he continues to shape the biotechnology and life sciences industry, ensuring transformative innovation thrives and fair deals flourish.